Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.

277 indexed citations
published 1951
Journal
PubMed

In The Last Decade

doi.org/w75683497 →

Countries where authors are citing Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.

Specialization
Citations

This map shows the geographic impact of Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. more than expected).

Fields of papers citing Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis..

About Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.

This paper, published in 1951, received 277 indexed citations . Written by Richard Gubner and Victor Ginsberg covering the research area of Pharmacology. It is primarily cited by scholars working on Rheumatology (150 citations), Immunology (84 citations) and Hematology (67 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w75683497.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026